Comparative differences in metabolic, mental health and perinatal outcomes of women with gestational diabetes in Ghana and Switzerland: the G-MUM study.
Details
Serval ID
serval:BIB_4A44E85630ED
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Comparative differences in metabolic, mental health and perinatal outcomes of women with gestational diabetes in Ghana and Switzerland: the G-MUM study.
Journal
BMC pregnancy and childbirth
ISSN
1471-2393 (Electronic)
ISSN-L
1471-2393
Publication state
Published
Issued date
15/04/2025
Peer-reviewed
Oui
Volume
25
Number
1
Pages
451
Language
english
Notes
Publication types: Journal Article ; Observational Study ; Comparative Study
Publication Status: epublish
Publication Status: epublish
Abstract
Gestational diabetes mellitus (GDM) prevalence (9-15%) is similar in Ghana and Switzerland, despite differences in sociodemographic characteristics, lifestyle, and healthcare systems. Contrary to Switzerland, data on the metabolic and mental health outcomes of women with GDM in Ghana is lacking. We compared the metabolic, mental health, and perinatal outcomes of GDM during pregnancy in Ghana and Switzerland.
This prospective observational study included 170 women with GDM from two cohorts (n = 88 in Switzerland, n = 82 in Ghana) who were followed-up until delivery. Primary outcomes were metabolic [HbA1c, gestational weight gain (GWG)], well-being (WHO-5), and depression symptoms (EPDS) during pregnancy. Secondary outcomes were obstetric and neonatal outcomes. Differences in metabolic, mental health and perinatal outcomes were tested using ANOVA, Chi-square test or ANCOVA when appropriate. For the perinatal outcomes, we adjusted for metabolic confounders.
Compared to the Swiss cohort (SC), the Ghana cohort (GC) had a higher pre-pregnancy weight (79.8 ± 18.0 vs. 71.8 ± 15.3 kg, p = 0.003) and BMI (30.8 ± 6.6 vs. 26.5 ± 4.9 kg/m <sup>2</sup> , p < 0.001), lower total GWG (6.2 ± 5.4 vs. 11.3 ± 5.8 kg, p < 0.001), but similar BMI-based excessive weight gain, higher fasting glucose (7.1 ± 2.4 vs. 5.1 ± 0.7 mmol/l) and HbA1c at GDM diagnosis (5.6 ± 1.0 vs. 5.3 ± 0.3%; both p ≤ 0.019), higher prevalence of previously undiagnosed pre-existing diabetes before 15-weeks gestational age (35.4% vs. 9.4%) and of metformin-treated women (84% vs. 1.1%, both p ≤ 0.001). The GC had higher well-being scores (74.4 ± 17.6 vs. 59.8 ± 18.3, p < 0.001), but similar symptoms of depression scores. In the GC, LGA (30% vs. 17%), and NICU hospitalizations (42% vs. 15%) were higher (all p ≤ 0.044) independent of HbA1c and pre-pregnancy BMI.
Women in the GC had worse metabolic outcomes but improved mental health during pregnancy. In this context, LGA and neonatal hospitalisations were higher, independent of HbA1c and pre-pregnancy BMI. Our results suggest the need for specialized GDM clinics in Ghana to improve metabolic and perinatal outcomes in women with GDM.
This prospective observational study included 170 women with GDM from two cohorts (n = 88 in Switzerland, n = 82 in Ghana) who were followed-up until delivery. Primary outcomes were metabolic [HbA1c, gestational weight gain (GWG)], well-being (WHO-5), and depression symptoms (EPDS) during pregnancy. Secondary outcomes were obstetric and neonatal outcomes. Differences in metabolic, mental health and perinatal outcomes were tested using ANOVA, Chi-square test or ANCOVA when appropriate. For the perinatal outcomes, we adjusted for metabolic confounders.
Compared to the Swiss cohort (SC), the Ghana cohort (GC) had a higher pre-pregnancy weight (79.8 ± 18.0 vs. 71.8 ± 15.3 kg, p = 0.003) and BMI (30.8 ± 6.6 vs. 26.5 ± 4.9 kg/m <sup>2</sup> , p < 0.001), lower total GWG (6.2 ± 5.4 vs. 11.3 ± 5.8 kg, p < 0.001), but similar BMI-based excessive weight gain, higher fasting glucose (7.1 ± 2.4 vs. 5.1 ± 0.7 mmol/l) and HbA1c at GDM diagnosis (5.6 ± 1.0 vs. 5.3 ± 0.3%; both p ≤ 0.019), higher prevalence of previously undiagnosed pre-existing diabetes before 15-weeks gestational age (35.4% vs. 9.4%) and of metformin-treated women (84% vs. 1.1%, both p ≤ 0.001). The GC had higher well-being scores (74.4 ± 17.6 vs. 59.8 ± 18.3, p < 0.001), but similar symptoms of depression scores. In the GC, LGA (30% vs. 17%), and NICU hospitalizations (42% vs. 15%) were higher (all p ≤ 0.044) independent of HbA1c and pre-pregnancy BMI.
Women in the GC had worse metabolic outcomes but improved mental health during pregnancy. In this context, LGA and neonatal hospitalisations were higher, independent of HbA1c and pre-pregnancy BMI. Our results suggest the need for specialized GDM clinics in Ghana to improve metabolic and perinatal outcomes in women with GDM.
Keywords
Humans, Female, Pregnancy, Diabetes, Gestational/epidemiology, Diabetes, Gestational/psychology, Diabetes, Gestational/metabolism, Ghana/epidemiology, Switzerland/epidemiology, Adult, Prospective Studies, Pregnancy Outcome/epidemiology, Glycated Hemoglobin/analysis, Glycated Hemoglobin/metabolism, Depression/epidemiology, Gestational Weight Gain, Mental Health, Infant, Newborn, Body Mass Index, Prevalence, Eating behaviour, Ghana, Mental health, gestational diabetes, Metabolic, Neonatal, Obstetric, Switzerland
Pubmed
Web of science
Open Access
Yes
Create date
17/04/2025 15:34
Last modification date
17/05/2025 7:09
Usage data
